Drug Utilization Study for azilsartan medoxomil in Germany

Study type

• Study topic:
  Disease /health condition

  Human medicinal product
• Study type:
  Non-interventional study
• Scope of the study:
  Drug utilisation
• Data collection methods:
  Secondary use of data

Non-interventional study

• Non-interventional study design:
  Cohort

Study drug and medical condition

• Name of medicine:
  EDARBI
• Study drug International non-proprietary name (INN) or common name:
  AZILSARTAN MEDOXOMIL
• Medical condition to be studied:
  Essential hypertension

Population studied

• Short description of the study population:
  All patients (of any age) with at least one prescription for azilsartan medoxomil (ATC code C09CA09) in the reporting period.; Patients who had a record in the database for at least 90 days before the index date were included.
• Age groups:
  Adults (18 to < 46 years)

  Adults (46 to < 65 years)

  Adults (65 to < 75 years)

  Adults (75 to < 85 years)

  Adults (85 years and over)
• Special population of interest:
  Other
• Special population of interest, other:
  Hypertensive patients
• Estimated number of subjects:
  1156

Study design details

• Main study objective:
  The primary study objective is to describe the population being prescribed azilsartan medoxomil in terms of demographics (age and gender) and ICD-10 CM based (co-) morbidities.
• Data analysis plan:
  Descriptive analysis of prescribing patterns.

Documents

Study results

Azilsmedox-5007 - Summary Results Document